231 related articles for article (PubMed ID: 19796674)
1. Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.
Ho L; Fivecoat H; Wang J; Pasinetti GM
Exp Gerontol; 2010 Jan; 45(1):15-22. PubMed ID: 19796674
[TBL] [Abstract][Full Text] [Related]
2. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
3. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.
Pasinetti GM; Ho L
Restor Neurol Neurosci; 2001; 18(2-3):137-42. PubMed ID: 11847436
[TBL] [Abstract][Full Text] [Related]
4. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.
Pasinetti GM
J Neurosci Res; 2001 Sep; 65(6):471-6. PubMed ID: 11550214
[TBL] [Abstract][Full Text] [Related]
5. Advent of Proteomic Tools for Diagnostic Biomarker Analysis in Alzheimer's Disease.
Singh M; Singh SP; Dubey PK; Rachana R ; Mani S; Yadav D; Agarwal M; Agarwal S; Agarwal V; Kaur H
Curr Protein Pept Sci; 2020; 21(10):965-977. PubMed ID: 32538723
[TBL] [Abstract][Full Text] [Related]
6. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
[TBL] [Abstract][Full Text] [Related]
7. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
Hurtado MO; Kohler I; de Lange EC
Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
9. Detecting Circulating MicroRNAs as Biomarkers in Alzheimer's Disease.
Kenny A; Jimenez-Mateos EM; Calero M; Medina M; Engel T
Methods Mol Biol; 2018; 1779():471-484. PubMed ID: 29886551
[TBL] [Abstract][Full Text] [Related]
10. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites.
Navas-Carrillo D; Rivera-Caravaca JM; Sampedro-Andrada A; Orenes-Piñero E
Crit Rev Clin Lab Sci; 2021 May; 58(3):167-179. PubMed ID: 33137264
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression.
Aharon A; Spector P; Ahmad RS; Horrany N; Sabbach A; Brenner B; Aharon-Peretz J
Mol Neurobiol; 2020 Oct; 57(10):4156-4169. PubMed ID: 32676990
[TBL] [Abstract][Full Text] [Related]
12. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
13. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review.
Scarano S; Lisi S; Ravelet C; Peyrin E; Minunni M
Anal Chim Acta; 2016 Oct; 940():21-37. PubMed ID: 27662756
[TBL] [Abstract][Full Text] [Related]
16. Circulating Biomarker Panels in Alzheimer's Disease.
Zafari S; Backes C; Meese E; Keller A
Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
Kong Y; Wu J; Yuan L
Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA expression profile of Alzheimer's disease and its clinical significance as biomarkers for the disease risk and progression.
Li Y; Fan H; Sun J; Ni M; Zhang L; Chen C; Hong X; Fang F; Zhang W; Ma P
Int J Biochem Cell Biol; 2020 Jun; 123():105747. PubMed ID: 32315771
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Wesenhagen KEJ; Teunissen CE; Visser PJ; Tijms BM
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):86-98. PubMed ID: 31694431
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in Sporadic and Familial Alzheimer's Disease.
Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
